Discontinued — last reported Q2 '22
GE HealthCare Technologies Short-Term Borrowings decreased by 98.6% to $7.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 99.7%, from $2.00B to $7.00M. Over 3 years (FY 2022 to FY 2025), Short-Term Borrowings shows an upward trend with a 223.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.00M | $5.00M | $5.00M | $7.00M | $1.01B | $1.01B | $1.01B | $1.01B | $1.50B | $2.00B | $2.01B | $2.01B | $508.00M | $7.00M |
| QoQ Change | — | -66.7% | +0.0% | +40.0% | >999% | +0.2% | -0.1% | +0.0% | +49.2% | +33.3% | +0.1% | +0.0% | -74.7% | -98.6% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | >999% | +49.3% | +98.6% | +99.1% | +99.1% | -66.2% | -99.7% |